{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:01:47Z","timestamp":1791406907249,"version":"4.3.3"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.peptides.2011.03.008","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T01:15:03Z","timestamp":1301534103000},"page":"1262-1269","source":"Crossref","is-referenced-by-count":19,"title":["Anti-allodynic effects of intrathecally and intracerebroventricularly administered 26RFa, an intrinsic agonist for GRP103, in the rat partial sciatic nerve ligation model"],"prefix":"10.1016","volume":"32","author":[{"given":"Tatsuo","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2011.03.008_bib0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cne.21400","article-title":"Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat","volume":"503","author":"Bruzzone","year":"2007","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.peptides.2011.03.008_bib0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1471-4159.2006.04090.x","article-title":"Anatomical distribution and biochemical characterization of the novel RFamide peptide 26RFa in the human hypothalamus and spinal cord","volume":"99","author":"Bruzzone","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.peptides.2011.03.008_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.peptides.2011.03.008_bib0020","doi-asserted-by":"crossref","first-page":"15247","DOI":"10.1073\/pnas.2434676100","article-title":"Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity","volume":"100","author":"Chartrel","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2011.03.008_bib0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2202-3-16","article-title":"Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury","volume":"3","author":"Costigan","year":"2002","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.peptides.2011.03.008_bib0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.peptides.2011.03.008_bib0035","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.peptides.2006.04.002","article-title":"In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist","volume":"27","author":"Fang","year":"2006","journal-title":"Peptide"},{"key":"10.1016\/j.peptides.2011.03.008_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2009.08.037","article-title":"Cardiovascular effects of intravenous administered 26RFa, a novel RFamide peptide ligand for GPR103, in anaesthetised rats","volume":"621","author":"Fang","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2011.03.008_bib0045","doi-asserted-by":"crossref","first-page":"46387","DOI":"10.1074\/jbc.M305270200","article-title":"A new peptidic ligand and its receptor regulating adrenal function in rats","volume":"278","author":"Fukusumi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2011.03.008_bib0050","series-title":"Wall and Melzack's textbook of pain","first-page":"947","article-title":"Central consequences of peripheral nerve damage","author":"H\u00f6kfelt","year":"2006"},{"key":"10.1016\/j.peptides.2011.03.008_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/nbdi.2000.0360","article-title":"Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain","volume":"8","author":"Ji","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.peptides.2011.03.008_bib0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainres.2006.08.055","article-title":"Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat","volume":"1119","author":"Kampe","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2011.03.008_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(02)02224-0","article-title":"Pharmacological characterization of human NPFF1 and NPFF2 receptors expressed in CHO cells by using NPY Y1 receptor antagonists","volume":"451","author":"Mollereau","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2011.03.008_bib0070","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1210\/en.2005-1580","article-title":"RFamide peptide QRFP43 causes obesity with hyperphagia and reduced thermogenesis in mice","volume":"147","author":"Moriya","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2011.03.008_bib0075","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.peptides.2008.07.024","article-title":"Central administration of the RFamide peptides, QRFP-26 and QRFP-43, increases high fat food intake in rats","volume":"29","author":"Primeaux","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2011.03.008_bib0080","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0014-2999(94)90822-2","article-title":"The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226","volume":"271","author":"Rudolf","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2011.03.008_bib0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.peptides.2011.03.008_bib0090","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1073\/pnas.0602371103","article-title":"A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice","volume":"103","author":"Takayasu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2011.03.008_bib0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0306-4522(02)00341-X","article-title":"Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases","volume":"114","author":"Wang","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2011.03.008_bib0100","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1073\/pnas.122231899","article-title":"Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain","volume":"99","author":"Xiao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2011.03.008_bib0105","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol Behav"},{"key":"10.1016\/j.peptides.2011.03.008_bib0110","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.peptides.2009.05.027","article-title":"Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test","volume":"30","author":"Yamamoto","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2011.03.008_bib0115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuroscience.2008.08.061","article-title":"Analgesic Effects of intrathecally administered 26RFa, an intrinsic agonist for GPR103, on formalin test and carrageenan test in rats","volume":"157","author":"Yamamoto","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2011.03.008_bib0120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00000542-199210000-00021","article-title":"Comparison of the antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat","volume":"77","author":"Yamamoto","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.peptides.2011.03.008_bib0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3959(92)90198-K","article-title":"Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists","volume":"49","author":"Yamamoto","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.peptides.2011.03.008_bib0130","series-title":"Biostatistical analysis","author":"Zar","year":"1984"},{"key":"10.1016\/j.peptides.2011.03.008_bib0135","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.peptides.2006.04.017","article-title":"Behavioral effects of 26RFamide and related peptides","volume":"27","author":"do Rego","year":"2006","journal-title":"Peptides"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978111001136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978111001136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T16:23:35Z","timestamp":1543854215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978111001136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0196978111001136"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2011.03.008","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}